US EditionGSK plc (NYSE:GSK) Receives $40.58 Consensus Target Price from Analysts
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
GSK plc (NYSE:GSK) Receives $40.58 Consensus Target Price from Analysts
Shares of GSK plc (NYSE:GSK – Get Free Report) have earned an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and three have issued a strong buy recommendation on the […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
